N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
about
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationAdipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota.Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-αMacrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation.The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell linePalmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway.The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Endocannabinoids in the gastrointestinal tract.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation.Secretion, isotopic labeling and deglycosylation of N-Acylethanolamine acid amidase for biophysical studies.Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models.Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.
P2860
Q26783956-3CDF8FD7-A6DC-467E-BABB-BB96A8117E98Q30357558-C7DD8C53-27CE-4412-9E94-C62D625F1341Q30372594-5DB4BA33-A72E-4F72-9B9E-F929AC60F4F9Q35871872-0CC9F4D2-65DA-460B-85F4-E00E61D4E458Q35999420-0CC1A6A2-938C-44F1-82E7-1B5DA074E965Q38639002-5A8A880C-B79D-4A31-9EF6-386AA40BB713Q38709659-97B8E27A-6216-4C2E-995B-E4E07F8E5E4AQ38789993-801CBC9A-74D0-46CE-BEA0-E4E546B43B62Q38822341-0E434DA1-6FB5-4F07-9F52-FA43B46416F8Q38918638-05980E2B-28F7-444D-9E6E-4BF8D37356F1Q38931168-D4D9096D-563E-4EC7-9EAC-559A5C458F29Q38937293-3C31E74F-9E1E-4A63-9EB9-7A4E1EE8492CQ41001072-CCE2925A-ECC7-4520-9EBB-F87B7E90EA45Q42239212-EC29AEA4-A233-4C5D-8D61-9EE84C193159Q47280730-813984C4-BB37-424C-A99D-4F24D64DBE3AQ55248842-69E7921E-EF27-4C14-98E6-83600112C78DQ55471337-03292E95-7318-418D-A9E9-512A2A9C8988
P2860
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
N-Acylethanolamine-hydrolyzing ...... nd counteracts murine colitis.
@en
type
label
N-Acylethanolamine-hydrolyzing ...... nd counteracts murine colitis.
@en
prefLabel
N-Acylethanolamine-hydrolyzing ...... nd counteracts murine colitis.
@en
P2093
P2860
P50
P356
P1433
P1476
N-Acylethanolamine-hydrolyzing ...... nd counteracts murine colitis.
@en
P2093
Didier M Lambert
Kumar V Subramanian
Mireille Alhouayek
Pauline Bottemanne
P2860
P304
P356
10.1096/FJ.14-255208
P407
P577
2014-11-10T00:00:00Z